AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,051,384 | -23.3% | 44,605 | -4.1% | 0.00% | -25.0% |
| Q2 2023 | $2,672,814 | +92.0% | 46,508 | +25.3% | 0.00% | +100.0% |
| Q1 2023 | $1,391,888 | -53.5% | 37,117 | -65.2% | 0.00% | -60.0% |
| Q4 2022 | $2,990,659 | -24.6% | 106,733 | -24.4% | 0.01% | -28.6% |
| Q3 2022 | $3,966,000 | +29.0% | 141,132 | +56.8% | 0.01% | +40.0% |
| Q2 2022 | $3,074,000 | +5.9% | 90,015 | +11.3% | 0.01% | +25.0% |
| Q1 2022 | $2,903,000 | +18.8% | 80,885 | -22.9% | 0.00% | +33.3% |
| Q4 2021 | $2,444,000 | +1.5% | 104,905 | -17.2% | 0.00% | 0.0% |
| Q3 2021 | $2,407,000 | -34.3% | 126,652 | -30.3% | 0.00% | -40.0% |
| Q2 2021 | $3,663,000 | -16.5% | 181,665 | -24.1% | 0.01% | -28.6% |
| Q1 2021 | $4,385,000 | -24.5% | 239,337 | -17.2% | 0.01% | -30.0% |
| Q4 2020 | $5,810,000 | +35.7% | 288,915 | +26.6% | 0.01% | +25.0% |
| Q3 2020 | $4,280,000 | +28.4% | 228,275 | +53.8% | 0.01% | +33.3% |
| Q2 2020 | $3,334,000 | +315.2% | 148,415 | +174.4% | 0.01% | +200.0% |
| Q1 2020 | $803,000 | -28.5% | 54,090 | -7.1% | 0.00% | 0.0% |
| Q4 2019 | $1,123,000 | -9.8% | 58,233 | -7.2% | 0.00% | 0.0% |
| Q3 2019 | $1,245,000 | -6.5% | 62,770 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $1,331,000 | +4.7% | 63,076 | +1.4% | 0.00% | 0.0% |
| Q1 2019 | $1,271,000 | +3.0% | 62,206 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $1,234,000 | +12.7% | 61,995 | +8.9% | 0.00% | 0.0% |
| Q3 2018 | $1,095,000 | +21.3% | 56,910 | -3.8% | 0.00% | +100.0% |
| Q2 2018 | $903,000 | -22.8% | 59,180 | -5.1% | 0.00% | -50.0% |
| Q1 2018 | $1,170,000 | +5.7% | 62,380 | +8.4% | 0.00% | 0.0% |
| Q4 2017 | $1,107,000 | -2.6% | 57,530 | -9.5% | 0.00% | 0.0% |
| Q3 2017 | $1,136,000 | +8.3% | 63,580 | +8.3% | 0.00% | 0.0% |
| Q2 2017 | $1,049,000 | -18.4% | 58,730 | -33.8% | 0.00% | 0.0% |
| Q1 2017 | $1,286,000 | -80.1% | 88,670 | -74.7% | 0.00% | -80.0% |
| Q4 2016 | $6,452,000 | -14.1% | 350,270 | -11.5% | 0.01% | -16.7% |
| Q3 2016 | $7,508,000 | – | 395,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |